| Project/Area Number |
26670019
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Gifu University |
|---|
Principal Investigator |
MaruYama Takashi 岐阜大学, 医学(系)研究科(研究院), 助教 (10622524)
|
|---|
| Project Period (FY) |
2014-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | IkB-zeta / IkBNS / T細胞 / 胸腺 / 成熟 / 核内IkappaBファミリー |
|---|
| Outline of Final Research Achievements |
This study focus on T cells maturation in the thymus and the role of nuclear IkB-zeta and IkB-NS.
T cell specific IkB-zeta deficient mice show less maturation rate of T cells, because more apoptotic gene expression. On the other hands, T cell maturation rate from IkBNS deficient mice was comparable compared with control mice. Interestingly, T cell specific IkBNS over-expressing mice shows inflammatory phenotype and have problems of T cell maturation.Interestingly, transcriptional activity and mechanisms of IkB-zeta and IkBNS is difference and do not compete against target genes, including IFN-gamma, IL-17A and ELAM-1.
|
